Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project.

Published

Journal Article (Review)

Seven oral triptans, which differ on a range of attributes important for treatment selection, are now available for treating migraine. US neurologists were surveyed to assess the relative importance of treatment attributes, prespecified by clinical relevance and availability of controlled study data, for selecting among oral triptans. Using a multiattribute decision model, we combined these data on the importance of treatment attributes with information on the relative performance of the oral triptans derived from a recent meta-analysis of controlled clinical trials.

Full Text

Duke Authors

Cited Authors

  • Dodick, DW; Lipton, RB; Ferrari, MD; Goadsby, PJ; McCrory, D; Cutrer, FM; Williams, P

Published Date

  • December 2004

Published In

Volume / Issue

  • 8 / 6

Start / End Page

  • 435 - 442

PubMed ID

  • 15509456

Pubmed Central ID

  • 15509456

International Standard Serial Number (ISSN)

  • 1531-3433

Language

  • eng

Conference Location

  • United States